Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Whitney

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Nature Methods|October 10, 2018
Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cellsPamela Y Ting, Albert E Parker, J Scott Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2005
Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in GhanaPratima L Raghunathan, Ellen A S Whitney, Kwame Asamoa, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2009
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritisKathleen M Gillooly, Mark A Pattoli, Tracy L Taylor, et al.
Molecular Microbiology|January 15, 2014
Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymeraseTaeksun Song, Yumi Park, Isdore Chola Shamputa, et al.
Elife|December 17, 2013
Rasgrp1 mutation increases naive T-cell CD44 expression and drives mTOR-dependent accumulation of Helios⁺ T cells and autoantibodiesStephen R Daley, Kristen M Coakley, Daniel Y Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2013
Identification of a small molecule with activity against drug-resistant and persistent tuberculosisFeng Wang, Dhinakaran Sambandan, Rajkumar Halder, et al.
Plos One|September 13, 2012
Identification of elongation factor G as the conserved cellular target of argyrin BBeat Nyfeler, Dominic Hoepfner, Deborah Palestrant, et al.
Biochemistry|August 25, 2004
Selective Itk inhibitors block T-cell activation and murine lung inflammationTai-An Lin, Kim W McIntyre, Jagabandhu Das, et al.
Nature|August 9, 2016
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessShilpi Khare, Advait S Nagle, Agnes Biggart, et al.
Science (New York, N.Y.)|November 19, 2011
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discoveryStephan Meister, David M Plouffe, Kelli L Kuhen, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Nature Methods|October 10, 2018
Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cellsPamela Y Ting, Albert E Parker, J Scott Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2005
Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in GhanaPratima L Raghunathan, Ellen A S Whitney, Kwame Asamoa, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2009
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritisKathleen M Gillooly, Mark A Pattoli, Tracy L Taylor, et al.
Molecular Microbiology|January 15, 2014
Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymeraseTaeksun Song, Yumi Park, Isdore Chola Shamputa, et al.
Elife|December 17, 2013
Rasgrp1 mutation increases naive T-cell CD44 expression and drives mTOR-dependent accumulation of Helios⁺ T cells and autoantibodiesStephen R Daley, Kristen M Coakley, Daniel Y Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2013
Identification of a small molecule with activity against drug-resistant and persistent tuberculosisFeng Wang, Dhinakaran Sambandan, Rajkumar Halder, et al.
Plos One|September 13, 2012
Identification of elongation factor G as the conserved cellular target of argyrin BBeat Nyfeler, Dominic Hoepfner, Deborah Palestrant, et al.
Biochemistry|August 25, 2004
Selective Itk inhibitors block T-cell activation and murine lung inflammationTai-An Lin, Kim W McIntyre, Jagabandhu Das, et al.
Nature|August 9, 2016
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessShilpi Khare, Advait S Nagle, Agnes Biggart, et al.
Science (New York, N.Y.)|November 19, 2011
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discoveryStephan Meister, David M Plouffe, Kelli L Kuhen, et al.
Pageof 17